
The West Australian: InteliCare defies Coronavirus gloom to list on ASX
While most companies aspiring to list on the ASX have faltered during the Coronavirus, telehealth company, InteliCare (ASX:ICR) has managed to get their listing away.
You are here: Home Investor & ASX
While most companies aspiring to list on the ASX have faltered during the Coronavirus, telehealth company, InteliCare (ASX:ICR) has managed to get their listing away.
In the lead up to listing on the ASX, InteliCare CEO and Managing Director, Jason Waller, speaks with 2GB’s Money News to discuss their IPO.
InteliLiving uses smart home technology driven by AI to give families peace of mind so adults can live independently safely during and after COVID-19. Powered by Microsoft Azure, available now on Azure Marketplace. Get InteliLiving on Azure Marketplace
In a market where the COVID-19 pandemic has rocked the waters, InteliCare is one of three small caps that still have positive growth metrics.
Watch InteliCare’s presentation at Stockhead’s video conference: The Future of TeleHealth. Jason Waller explains InteliCare and its market position.
Continuing InteliCare’s push to list on the ASX during the COVID-19 pandemic, lead manager, JP Equity, sent the allocations for the $5.5 million offer.
As confidence in duress pendants decreases, InteliCare offers a reliable health & wellbeing solution to support seniors living at home.
InteliCare’s CEO Jason Waller joins a routable of experts in aged care, medtech, and care tech discuss a range of topics to discuss increased funding.
InteliCare is uniquely positioned to help aging Australians that want to avoid full time aged care facilities but are still on the waiting list to receive a Home Care Package from My Aged Care.
The Sydney Morning Herald spoke with InteliCare CEO and Managing Director, Jason Waller, to discuss InteliCare’s momentum on the back of the coronavirus pandemic.